Tex Clark
Analyst · William Blair. Please go ahead with your question
Thank you, Barry. I will now address our performance in more or detail. In the third quarter, revenue was $277.4 million, a decline of approximately 3% over Q3 of last year. U.S. average daily sales declined to 3.5%, while Canada average daily sales increased to 1.3% in local currency. Sales improved each month during the quarter, and in an effort to normalized results against the surge benefit of PPE sales in 2020, I would note our two-year CAGR was 6.6%. We saw a continued growth in core product lines. And our private label offering once again, increased as a percentage of total sales. Our performance was highlighted by growth in our managed sales channels, as well as e-commerce orders, which continue to increase as a percentage of total transactions. Customer demand expanded in the quarter and the rate of growth improved each month. However, due to the supply chain environment, we experienced extended fulfillment times and continued to see an elevated number of open orders for both stock and drop ship products. We are cautiously up to that the supply chain will normalize over the next six months. Consumable products within the pandemic assortment including PPE and sanitizing supplies made up approximately 3% of sales in the third quarter, which is in line with the second quarter of this year and our pre-pandemic levels in the low-single digits. This compares to approximately 11% of sales in the third quarter of last year. Customer demand for non-PPE products was healthy in the quarter, reflecting the continued mix shift to core product lines. I would like to remind everyone that the fourth quarter of 2021 will have 61 selling days. And the fourth quarter last year contained 66 selling days. In addition, fourth quarter of 2020, DDS improved approximately 16%. And PPE and sanitizing supplies made up roughly 9% of sales. Gross profit for the quarter was $102 million, roughly flat from last year. Gross margin was a quarterly record of 36.8%, up 100 basis points from the prior year and up 80 basis points on a consecutive quarter basis. Gross margin performance reflects the impact of price rationalization, favorable product margins as the private label offering capture a larger share of our sales mix and the benefit of lower costs FIFO inventory sell through with increasing selling prices. While supply chain pressures including ocean freight remain elevated to date, we have been able to largely mitigate their impact. We anticipate that our ongoing initiatives to drive higher margin sourcing channels, price analytics, and freight optimization should help us maintain our margin profile in the current environment, subject to the normal variations arising from product and customer mix, which do vary by season. Selling distribution and administrative spending for the quarter was $71.4 million or 25.7% of net sales, up 90 basis points as a percentage of sales from last year and down 120 basis points on a sequential quarter basis. SG&A primarily reflects increased marketing investments to support customer demand shift to core product lines and private label, head away from PPE as well as increased distribution center compensation. We continue to maintain strong cost controls, but as the labor market remains tight, we do expect to see additional wage pressure. Operating income from continuing operations was $30.6 million and operating margin was 11% equal to our record high margin quarter realized in the third quarter of 2020. Total depreciation and amortization expense in the quarter was $0.9 million. Capital Expenditures for the third quarter were $1.3 million, and we expect total 2021 capital expenditures in the range of $4 million to $5 million, primarily comprised of maintenance related capital. Operating cash flow from continuing operations was $18.8 million in the quarter. Let me now turn to our balance sheet. We have a very strong liquid balance sheet with the current ratio of 1.6 to 1. As of September 30th, we had over $54 million in cash, zero debt and availability of $72.5 million of our $75 million credit facility, which was recently extended through October 2026 on largely the same terms. We maintained significant flexibility to fully execute on our strategic plan and continue to fund our quarterly dividend. As a result, our Board of Directors declared a quarterly dividend of $0.16 per share of common stock, and we anticipate continuing a regular quarterly dividend in the future. This concludes our prepared remarks today. Operator, please open the call for questions.